Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs: a case-control study.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Gastroenterology

• Publication date

  1999-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0016-5085(99)70494-4PMID 10348813
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Eradication of H. Pylori versus maintenance acid suppression to prevent recurrent ulcer hemorrhage in high risk NSAID users: A prospective randomizd study

  1998cited by this paper
• Meta-analysis of risk factors for peptic ulcer. Nonsteroidal antiinflammatory drugs, Helicobacter pylori, and smoking.

  1997cited by this paper
• Role of Helicobacter pylori Infection on Upper Gastrointestinal Bleeding in the Elderly (A Case-Control Study)

  1997cited by this paper
• Peptic ulcer bleeding in the elderly: relative roles ofHelicobacter pylori and non-steroidal anti-inflammatory drugs

  1997cited by this paper
• Pharmacoepidemiology (2nd ed)

  1996cited by this paper
• Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis

  1996cited by this paper
• Seroprevalence of immunoglobulin G, M, and A antibodies to Helicobacter pylori in an unselected Danish population.

  1996cited by this paper
• Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease.

  1995cited by this paper
• Accuracy of diagnostic methods used for epidemiological studies of Helicobacter pylori.

  1995cited by this paper
• Helicobacter pylori eradication reduces the rate of rebleeding in ulcer hemorrhage.

  1995cited by this paper
• The role of Helicobacter pylori eradication in the management of acute bleeding peptic ulcer.

  1995cited by this paper
• Prophylactic aspirin and risk of peptic ulcer bleeding

  1995cited by this paper
• Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs.

  1994cited by this paper
• Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs.

  1994cited by this paper
• Bleeding peptic ulcer.

  1994cited by this paper
• Evaluation of eight commercial kits for Helicobacter pylori IgG antibody detection

  1993cited by this paper
• Confidence interval estimation of interaction.

  1992cited by this paper
• Long-term nonsteroidal antiinflammatory drug use and Helicobacter pylori infection.

  1991cited by this paper
• Foundations of Epidemiology

  1980cited by this paper

• Prevalence of Helicobacter Pylori Infection in Patients with Upper Gastrointestinal Bleeding

  2019cites this paper
• Helicobacter pylori infection and the risk of upper gastrointestinal bleeding in low dose aspirin users: systematic review and meta‐analysis

  2018cites this paper
• Clinical pharmacology of acetylsalicylic acid as an anti-thrombotic agent

  2018cites this paper
• Pathophysiology and Risk Factors in Peptic Ulcer Disease

  2017cites this paper
• Nonvariceal upper gastrointestinal bleeding in elderly people: Clinical outcomes and prognostic factors

  2017cites this paper
• The incidence of Non Steroidal Anti-Inflammatory drugs as a causative agent of peptic ulcer diseases

  2016cites this paper
• Acid-reducing vagotomy is associated with reduced risk of subsequent ischemic heart disease in complicated peptic ulcer

  2016cites this paper
• Etiological Factors in Urgent Gastroduodenal Ulcer

  2015cites this paper
• Endos507 8__15

  2014cites this paper
• Approach to Helicobacter pylori infection in geriatric population.

  2014cites this paper
• Comparison of re-bleeding rate after endoscopic hemostasis of aspirin, NSAIDs and peptic gastroduodenal ulcers

  2013cites this paper
• Nonsteroidal Anti-Inflammatory Drugs

  2012cites this paper
• Chronic NSAIDs Therapy and Upper Gastrointestinal Tract – Mechanism of Injury, Mucosal Defense, Risk Factors for Complication Development and Clinical Management

  2012cites this paper
• 484 Paradoxical Effects of H. pylori Infection on Low-Dose Aspirin Induced Gastropathy Depending on the Gastric Acid Secretion Level

  2012cites this paper
• Biphasic effects of H. pylori infection on low-dose aspirin-induced gastropathy depending on the gastric acid secretion level

  2012cites this paper
• Helicobacter pylori and risk of upper gastrointestinal bleeding among users of selective serotonin reuptake inhibitors

  2011cites this paper
• Risk factors for peptic ulcer bleeding in terms of Helicobacter pylori, NSAIDs, and antiplatelet agents

  2011cites this paper
• Has H. pylori Prevalence in Bleeding Peptic Ulcer Been Underestimated? A Meta-Regression

  2011cites this paper
• Underutilization of gastroprotective drugs in patients receiving non-steroidal anti-inflammatory drugs.

  2011cites this paper
• Gastric acid secretion level modulates the association between Helicobacter pylori infection and low-dose aspirin-induced gastropathy

  2011cites this paper
• The Interaction of H. pylori and Non-Steroidal Anti-Inflammatory Drugs and Their Effect on Induction of Peptic Ulcer

  2011cites this paper
• Drug-induced Injury of the Gastrointestinal Tract.

  2010cites this paper
• Role of Helicobacter pylori Infection in Gastroduodenal Damage in Patients Starting NSAID Therapy: 4 Months Follow-Up Study

  2010cites this paper
• Helicobacter pylori and NSAIDs

  2010cites this paper
• [Guidelines of prevention and treatment for NSAID-related peptic ulcers].

  2009cites this paper
• Interactions between anti-ulcer drugs and non-steroidal anti-inflammatory drugs in cirrhotic patients with bleeding esophagogastric varices.

  2009cites this paper
• GI Bleeding in the Elderly

  2008cites this paper
• Use of NSAIDs and infection with Helicobacter pylori--what does the rheumatologist need to know?

  2008cites this paper
• Epidemiology of acute upper gastrointestinal bleeding.

  2008cites this paper
• Nonsteroidal anti‐inflammatory drug use as a risk factor for gastro‐oesophageal reflux disease: an observational study

  2008cites this paper
• The Treatment and Risk Factors of Peptic Ulcer Bleeding

  2007influential citation
• Aspirin and gastrointestinal toxicity.

  2007cites this paper
• Gastric Cancer Risk and Erythrocyte Composition of Docosahexaenoic Acid with Anti-inflammatory Effects

  2007cites this paper
• EVIDENCE IN SUPPORT OF A CAUSATIVE RELATIONSHIP BETWEEN HELICOBACTER PYLORI AND PEPTIC ULCER DISEASE

  2007influential citation
• Aspirin and gastrointestinal toxicity.

  2007cites this paper
• Analysis of the risk factors and their combinations in acute gastroduodenal ulcer bleeding: A case-control study

  2007influential citation
• [Significance of Helicobacter pylori infection and nonsteroidal anti-inflammatory drugs in patients with bleeding from upper part of the gastrointestinal tract].

  2007cites this paper
• Treatment of H. pylori infection: Current recommendations

  2007cites this paper
• Bleeding Peptic Ulcer in the Elderly

  2007cites this paper
• Case-control study on the association of upper gastrointestinal bleeding and nonsteroidal anti-inflammatory drugs in Japan

  2006influential citation
• Effects of Helicobacter pylori and nonsteroidal anti-inflammatory drugs on peptic ulcer disease: a systematic review.

  2006cites this paper
• The association of Helicobacter pylori infection and nonsteroidal anti-inflammatory drugs in peptic ulcer disease.

  2006cites this paper
• A FREE CONTINUING EDUCATION LESSON Update on the Management of Acid-Related Disorders : A Canadian Perspective

  2006cites this paper
• Usefulness of a delayed test for the diagnosis of Helicobacter pylori infection in bleeding peptic ulcer

  2006cites this paper
• Variations reported in surgical practice for bleeding duodenal ulcers.

  2006cites this paper
• Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report

  2006cites this paper
• Counting the true cost of antiplatelet therapy for stroke prevention.

  2005cites this paper
• Prediction of UGIB event in NSAID users: a model development.

  2005cites this paper
• [Not Available].

  2005cites this paper
• Helicobacter pylori y gastroprotección

  2005cites this paper
• Gastrointestinal effects of selective and non-selective non-steroidal anti-inflammatory drugs.

  2005cites this paper
• Protective Effect of H pylori Infection in Non- Steroidal Anti-Inflammatory Drug Users

  2005cites this paper
• Meta‐analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users

  2005cites this paper
• Helicobacter pylori y gastroprotección

  2005cites this paper
• Helicobacter pylori and nonsteroidal anti-inflammatory drugs in perforations and bleeding of peptic ulcers.

  2005cites this paper
• Frequent monthly use of selected non‐prescription and prescription non‐narcotic analgesics among U.S. adults

  2005cites this paper
• SECONDARY PREVENTION OF UPPER GASTROINTESTINAL BLEEDING IN LOW DOSE ASPIRIN USERS INFECTED WITH HELICOBACTER PYLORI

  2005cites this paper
• Helicobacter pylori infection and surgical disease--part II.

  2005cites this paper
• Impact of COX-2 inhibitors in common clinical practice a gastroenterologist's perspective.

  2005cites this paper
• Peptic ulcer disease in dyspeptic patients with ischemic heart disease: search and treat?

  2005cites this paper
• Role of Helicobacter pylori eradication in aspirin or non-steroidal anti-inflammatory drug users.

  2005cites this paper
• Outcome of peptic ulcer bleeding, nonsteroidal anti-inflammatory drug use, and Helicobacter pylori infection.

  2005cites this paper
• Medikamentös induzierte Gastroenteropathien

  2005cites this paper
• Should NSAID/low‐dose aspirin takers be tested routinely for H. pylori infection and treated if positive? Implications for primary risk of ulcer and ulcer relapse after initial healing

  2004cites this paper
• Laparoscopic Esophageal Myotomy

  2004cites this paper
• The Selective Cyclooxygenase-2 Inhibitor Nimesulide Prevents Helicobacter pylori-Associated Gastric Cancer Development in a Mouse Model

  2004cites this paper
• Gastropat?a por antiinflamatorios no esteroideos

  2004cites this paper
• Development in a Mouse Model -Associated Gastric Cancer Helicobacter pylori Prevents The Selective Cyclooxygenase-2 Inhibitor Nimesulide

  2004cites this paper
• Clinical significance of cytotoxin-associated gene A status of Helicobacter pylori among non-steroidal anti-inflammatory drug users with peptic ulcer bleeding: a multicenter case-control study

  2004cites this paper
• Effects of indomethacin and rofecoxib on gastric mucosal damage in normal and Helicobacter pylori-infected mongolian gerbils.

  2004cites this paper
• NSAID Gastric Ulceration: Predictive Value of Gastric pH, Mucosal Density of Polymorphonuclear Leukocytes, or Levels of IL-8 or Nitrite

  2004cites this paper
• [Epidemiology of digestive complications associated with use of low-dose aspirin].

  2004cites this paper
• Épidémiologie des complications digestives liées à l’aspirine à faible dose

  2004cites this paper
• Impact de l’infection à Helicobacter pylori sur le risque de complications gastro-duodénales des traitements anti-inflammatoires non stéroïdiens

  2004cites this paper
• Effect of helicobacter pylori infection on the risk of upper gastrointestinal bleeding in users of nonsteroidal anti-inflammatory drugs.

  2004cites this paper
• Prevention of nonsteroidal anti-inflammatory drug-associated gastrointestinal symptoms and ulcer complications.

  2004cites this paper
• Risk of Upper Gastrointestinal Injury and Events in Patients Treated With Cyclooxygenase (COX)-1/COX-2 Nonsteroidal Antiinflammatory Drugs (NSAIDs), COX-2 Selective NSAIDs, and Gastroprotective Cotherapy: An Appraisal of the Literature

  2004cites this paper
• SURVEYING THE SIDE EFFECTS OF NON-STEROIDAL ANTI INFLAMMATORY DRUGS AMONG PATIENTS WITH HELICOBACTER PYLORI INFECTION AND NON-INFECTED SUBJECTS

  2003cites this paper
• How Helicobacter pylori Changed the Life of Surgeons

  2003cites this paper
• Nonvariceal upper gastrointestinal bleeding.

  2003cites this paper
• Risk factors for adverse events in analgesic drug users: results from the PAIN study

  2003cites this paper
• Effect of treatment of Helicobacter pylori on the prevention of gastroduodenal ulcers in patients receiving long‐term NSAIDs: a double‐blind, placebo‐controlled trial

  2003cites this paper
• Estrategia clínica para la prevención de los efectos adversos sobre el tracto digestivo de los antiinflamatorios no esteroideos

  2003cites this paper
• Healing of Helicobacter pylori gastric ulcers: only eradication matters.

  2003cites this paper
• [Gastropathy caused by non-steroidal anti-inflammatory agents and its association with Helicobacter pylori].

  2003cites this paper
• Relationship between non‐steroidal anti‐inflammatory drug use and Helicobacter pylori infection in bleeding or uncomplicated peptic ulcers: A case‐control study

  2003cites this paper
• [Should Helicobacter pylori infection be tested and eradicated in patients treated or about to be treated with aspirin or nonsteroidal anti-inflammatory drugs?].

  2003cites this paper
• [Clinical strategy to prevent the gastrointestinal adverse effects of nonsteroidal anti-inflammatory agents].

  2003cites this paper
• Lansoprazole reduces ulcer relapse after eradication of Helicobacter pylori in nonsteroidal anti‐inflammatory drug users – a randomized trial

  2003cites this paper
• [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].

  2003cites this paper
• Helicobacter pylori and Bleeding Peptic Ulcer: What is the Prevalence of the Infection in Patients with this Complication?

  2003cites this paper
• Erosive gastroduodenitis and Helicobacter pylori infection.

  2003cites this paper
• Interactions between Helicobacter pylori and other risk factors for peptic ulcer bleeding

  2002cites this paper
• Helicobacter pylori infection in peptic ulcer haemorrhage

  2002cites this paper
• Helicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low‐dose aspirin

  2002cites this paper
• translational physiology NSAIDs counteract H. pylori VacA toxin-induced cell vacuolation in MKN 28 gastric mucosal cells

  2002cites this paper
• Gastrointestinal safety and tolerability of nonselective nonsteroidal anti-inflammatory agents and cyclooxygenase-2-selective inhibitors.

  2002cites this paper
• Results of systematic screening for serious gastrointestinal bleeding associated with NSAIDs in Rostock hospitals.

  2002cites this paper
• Helicobacter pylori and nonsteroidal anti-inflammatory drug interactions in bleeding ulcers.

  2002cites this paper
• Effect of H. pylori status on gastric ulcer healing in patients continuing nonsteroidal anti-inflammatory therapy and receiving treatment with lansoprazole or ranitidine

  2002cites this paper